188 related articles for article (PubMed ID: 30503134)
21. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
[TBL] [Abstract][Full Text] [Related]
22. Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients.
Tsampras N; Roberts SA; Gould D; Fitzgerald CT
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12797. PubMed ID: 29168588
[TBL] [Abstract][Full Text] [Related]
23. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
24. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
25. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
Turan V; Bedoschi G; Moy F; Oktay K
Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
[TBL] [Abstract][Full Text] [Related]
26. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
[TBL] [Abstract][Full Text] [Related]
27. Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles?
Yoon SH; Lee JY; Kim SN; Chung HW; Park SY; Lee C
Fertil Steril; 2016 Oct; 106(5):1083-1092.e5. PubMed ID: 27336211
[TBL] [Abstract][Full Text] [Related]
28. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
Creux H; Monnier P; Son WY; Tulandi T; Buckett W
Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
[TBL] [Abstract][Full Text] [Related]
29. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment.
Domingo J; Guillén V; Ayllón Y; Martínez M; Muñoz E; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Apr; 97(4):930-4. PubMed ID: 22283969
[TBL] [Abstract][Full Text] [Related]
30. Lag time from ovulation trigger to oocyte aspiration and oocyte maturity in assisted reproductive technology cycles: a retrospective study.
Weiss A; Neril R; Geslevich J; Lavee M; Beck-Fruchter R; Golan J; Shalev E
Fertil Steril; 2014 Aug; 102(2):419-23. PubMed ID: 24880653
[TBL] [Abstract][Full Text] [Related]
31. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
32. Ovarian stimulation in the luteal phase: systematic review and meta-analysis.
Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES
J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151
[TBL] [Abstract][Full Text] [Related]
33. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
[TBL] [Abstract][Full Text] [Related]
35. Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years.
Tannus S; Turki R; Cohen Y; Son WY; Shavit T; Dahan MH
Fertil Steril; 2017 Jun; 107(6):1323-1328.e2. PubMed ID: 28501366
[TBL] [Abstract][Full Text] [Related]
36. Ovarian response to stimulation for fertility preservation in women with hematologic cancer.
Brun T; Dion L; Jaillard S; Bales D; Domin M; Lavoué V; Levêque J; Houot R; Duros S
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101925. PubMed ID: 33010467
[TBL] [Abstract][Full Text] [Related]
37. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
[TBL] [Abstract][Full Text] [Related]
38. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients.
Goldman RH; Racowsky C; Farland LV; Munné S; Ribustello L; Fox JH
Hum Reprod; 2017 Apr; 32(4):853-859. PubMed ID: 28166330
[TBL] [Abstract][Full Text] [Related]
39. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
40. Influence of stage and grade of breast cancer on fertility preservation outcome in reproductive-aged women.
Volodarsky-Perel A; Cai E; Tulandi T; Son WY; Suarthana E; Buckett W
Reprod Biomed Online; 2020 Feb; 40(2):215-222. PubMed ID: 31953011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
